You are here: Industry Insights > Dr Reddy

News List

Dr Reddy’s Laboratories launches penicillamine capsules in US expresspharma
August 28, 2020
It is a chelating agent used in the treatment of Wilson’s disease and to reduce cystine excretion in cystinuria and to treat patients with severe, active rheumatoid arthritis.
Dr Reddy’s Laboratories launches AVIGAN (favipiravir) in India expresspharma
August 20, 2020
Dr Reddy’s Laboratories announced the launch of AVIGAN (favipiravir) 200 mg tablets in India.
Dr Reddy’s Laboratories launches generic Ciprodex Otic Suspension, USP in US expresspharma
August 11, 2020
It is available as 7.5 mL fill in a 10 mL bottle.
DRL receives US FDA’s approval for XEGLYZETM (abametapir) lotion expresspharma
July 28, 2020
XEGLYZE is indicated for the topical treatment of head lice infestation in patients 6 months of age and older.
Dr Reddy’s Laboratories launch OTC Nicotine Polacrilex Lozenges in the US expresspharma
July 15, 2020
Dr Reddy’s Laboratories announced the launch of over-the-counter (OTC) Nicotine Polacrilex Lozenges, 2 mg and 4 mg, the store brand version of Nicorette lozenges in the US market.
Dr Reddy’s signs agreement with FUJIFILM and Global Response Aid for Avigan (favipiravir) expresspharma
July 02, 2020
Dr Reddy’s would have exclusive rights for development, selling and distribution of Avigan in India.
Expect to launch 25 products in US this fiscal: Dr Reddy’s expresspharma
June 30, 2020
As of March 31, 2020, the company has 99 cumulative filings pending for approval with the US Food and Drug Administration (US FDA), including two new drug approvals (NDAs).
Dr Reddy’s Laboratories launch Abiraterone Acetate Tablets USP in the US expresspharma
June 22, 2020
Dr Reddy’s Laboratories announced the launch of Abiraterone Acetate Tablets USP, 250 mg, a therapeutic equivalent generic version of Zytiga (abiraterone acetate) approved by the US Food and Drug Administration (USFDA).
Dr Reddy’s announces launch of Colchicine Tablets USP in the US expresspharma
June 16, 2020
It is available in 0.6 mg tablets in bottle count sizes of 30s and 100s.
Dr Reddy’s signs licensing agreement with Gilead Sciences for remdesivir expresspharma
June 15, 2020
Dr Reddy’s will receive technology transfer from Gilead for manufacturing of this drug and needs to do the manufacturing scale-up and obtain regulatory approval for marketing of this drug in respective countries.

Previous page 1 2 3 4 5 Next page